Search

Your search keyword '"Valentina Cesario"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Valentina Cesario" Remove constraint Author: "Valentina Cesario" Journal digestive and liver disease Remove constraint Journal: digestive and liver disease
37 results on '"Valentina Cesario"'

Search Results

1. OC.04.3 PATIENT-TARGETED AND MULTIDISCIPLINARY MANAGEMENT IMPROVES SURVIVAL IN PATIENTS WITH HCC: THE HEPATOCATT EXPERIENCE

2. P.16.5 SAFETY AND EFFECTIVENESS OF PLASMA EXCHANGE IN SEVERE LIVER FAILURE

3. P.11.15 IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE

4. P.06.16 EFFICACY OF AMYTRIPTILINE IN IMPROVING INTESTINAL PERMEABILITY AND QUALITY OF LIFE IN PATIENTS WITH IBS

5. P.13.7 COMPARISON BETWEEN TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS RADIOFREQUENCY ABLATION (TACE-RFA) FOR TREATMENT OF INTERMEDIATE HEPATOCELLULAR CARCINOMA (HCC)

6. P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

8. F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience

9. P.1.303: HIGH DOSE AMOXICILLIN-BASED FIRST LINE REGIMEN IS EQUIVALENT TO SEQUENTIAL THERAPY IN THE ERADICATION OF H. PYLORI INFECTION

10. OC.04.1: NICKEL FREE-DIET ENHANCES HELICOBACTER PYLORI ERADICATION RATE

11. P.17.5 TREATMENT OF 'COMPLEX' UNRESECTABLE HEPATOCELLULAR CARCINOMA: PRELIMINARY RESULTS OF NEW THERAPEUTIC APPROACH (SINGLE-STEP BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE-RFA)

12. P.17.4 DOWNSTAGING THERAPY IN PATIENTS WITH INTERMEDIATE STAGE HCC (BCLC B) AS BRIDGE FOR TRANSPLANTATION: THE HEPATOCATT EXPERIENCE

13. PA.186 FABRY DISEASE AND SMALL INTESTINAL BACTERIAL OVERGROWTH: PREVALENCE AND CORRELATION WITH GASTROINTESTINAL SYMPTOMS

14. P.13.5 TREATMENT OF SINGLE-NODULE HEPATOCELLULAR CARCINOMA (HCC): COMPARISON BETWEEN SURGICAL RESECTION AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS RADIOFREQUENCY

15. P.09.7 GELATINE TANNATE REDUCES ANTIBIOTICS ASSOCIATED SIDE-EFFECTS OF ANTI-HELICOBACTER PYLORI FIRST-LINE THERAPY

16. P.13.6 TREATMENT OF PORTAL VEIN TUMOR THROMBOSIS (PVTT) CAN IMPACT SURVIVAL OF PATIENTS WITH ADVANCED HCC?

17. T-43 Treatment of single-nodule hepatocarcinoma: comparison between surgical resection and transarterial chemoembolization combined with radiofrequency

18. P.03.12 SINGLE-STEP BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) FOR TREATMENT OF 'COMPLEX' UNRESECTABLE HEPATOCELLULAR CARCINOMA

19. P.19.14 HIGH DOSE AMOXICILLIN-BASED FIRST LINE REGIMEN COMPARED TO SEQUENTIAL THERAPY IN THE ERADICATION OF H. PYLORI INFECTION

20. P.15.4 SINGLE-STEP COMBINED THERAPY FOR TREATMENT OF SNGLE LARGE UNRESECTABLE HEPATOCELLULAR CARCINOMA: BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE). INITIAL RESULTS

21. P.15.6 SINGLE-STEP COMBINED THERAPY FOR TREATMENT OF MULTINODULAR UNRESECTABLE HCC: BALLOON-OCCLUDED PERCUTANEOUS RADIOFREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE). INITIAL RESULTS AND MEDIUM-TERM FOLLOW-UP

22. P.04.15 NEW THERAPEUTIC PERSPECTIVES FOR MANAGEMENT OF ADVANCED HEPATOCELLULAR CARCINOMA WITH HEPATIC ARTERIOVENOUS FISTULA: BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE)

23. P.03.17 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY

25. P.08.8 LACK OF RESPONSE AND TUMOR RECURRENCE AFTER MULTIMODAL REPEATED TREATMENT

26. F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma

27. P.1.161: HCC PERSONALIZED TREATMENT IN THE MULTIMODAL MANAGEMENT ERA: HEPATOCAT GROUP EXPERIENCE

28. P.1.175: NEW PERSPECTIVES IN TREATMENT OF MULTINODULAR UNRESECTABLE HEPATOCELLULAR CARCINOMA: BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMOABLATION (RFA) FOLLOWED BY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE)

29. P.1.94: HEPATIC DECOMPENSATION AFTER TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA: PREDICTIVE VALUE OF MELD AND MELD-NA

30. CS.2.5 INCREASED ANTIOXIDANT CAPACITY AS MARKER OF HEPATIC CANCER STEM CELLS: TOWARD A METABOLISM-BASED STRATEGY AGAINST LIVER TUMORS

31. 27 LIVER CANCER STEM CELLS MIGHT BE IDENTIFIED BY THEIR LOW CONTENT OF REACTIVE OXYGEN SPECIES: IMPLICATIONS FOR HEPATIC TUMOR TREATMENT

32. CYCLIC TREATMENT WITH MESALAZINE IN PREVENTING RECURRENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH AFTER ANTIBIOTIC TREATMENT

33. H. PYLORI INFECTION AND SMALL INTESTINE BACTERIAL OVERGROWTH IN PATIENTS WITH FABRY' DISEASE: DO THEY ENHANCE THE EXPRESSION OF FABRY'-RELATED GASTROINTESTINAL SYMPTOMS?

34. PA.55 SMALL INTESTINAL BACTERIAL OVERGROWTH RECURRENCE AFTER ANTIBIOTIC THERAPY

35. PA.49 LACTOSE MALABSORPTION IN PATIENTS AFFECTED BY RECURRENT VAGINITIS

36. OC3.08.2 SMALL INTESTINAL BACTERIAL OVERGROWTH IN A CHILDREN POPULATION AFFECTED BY IRRITABLE BOWEL SYNDROME: A CASE-CONTROL STUDY

37. PA.29 IMPACT OF L. REUTERII SUPPLEMENTATION ON ANTI-H. PYLORI SECOND LINE THERAPY-RELATED

Catalog

Books, media, physical & digital resources